Biosimilar - Global Market Updates

Health

Lupin Completes Phase 3 Trials for Lucentis Biosimilar

John - August 6, 2024 0

Lupin Limited announced the successful completion of global Phase 3 trials for its Lucentis (ranibizumab) biosimilar, LUBT010. This trial, involving 600 patients from India,...

HDFC Bank’s Chief Economist Comments on RBI’s Steady Repo Rate Decision

John - August 8, 2024

Dr. Mansukh Mandaviya Hails Youth Volunteers as Torchbearers of Change on Pre-Independence Day Event

John - August 14, 2024

Narendra Modi Congratulates Paetongtarn Shinawatra on Election as Thai Prime Minister

John - August 18, 2024

Teleportation: The Future of Instant Travel

Clara Bennett - June 9, 2024

Tag: Biosimilar

Lupin Completes Phase 3 Trials for Lucentis Biosimilar

EDITOR PICKS

HDFC Bank’s Chief Economist Comments on RBI’s Steady Repo Rate Decision

Dr. Mansukh Mandaviya Hails Youth Volunteers as Torchbearers of Change on Pre-Independence Day Event

Narendra Modi Congratulates Paetongtarn Shinawatra on Election as Thai Prime Minister

Teleportation: The Future of Instant Travel

EVEN MORE NEWS

Samsung Food+ Upgrades AI-Powered Features for Smarter, Healthier Cooking at IFA...

NVIDIA Launches AI-Driven NIM Agent Blueprint to Revolutionize Drug Discovery

Samsung Partners With Qualcomm to Enhance In-Vehicle Infotainment Systems

POPULAR CATEGORY